Published online November 1, 2004
PEDIATRICS Vol. 114 No. 5 November 2004, pp. 1305-1311 (doi:10.1542/peds.2004-0204)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, M. C.
Related Collections
Right arrow Premature & Newborn

Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates

Michele C. Walsh, MD, MS*, Qing Yao, PhD{ddagger}, Patricia Gettner, RN§, Ellen Hale, RN||, Monica Collins, RN, Angelita Hensman, RN#, Ruth Everette, RN**, Nancy Peters, RN{ddagger}{ddagger}, Nancy Miller, RN§§, Gerry Muran, RN||||, Kathy Auten, BS¶¶, Nancy Newman, RN*, Gina Rowan, RN##, Cathy Grisby, RN***, Kathy Arnell, RN{ddagger}{ddagger}{ddagger}, Lucy Miller, RN§§§, Bethany Ball, BS||||||, Georgia McDavid, RN¶¶¶ for the National Institute of Child Health and Human Development Neonatal Research Network

* Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio
{ddagger} Department of Pediatrics, Research Triangle Institute, Research Triangle Park, North Carolina
§ Department of Pediatrics, Yale University, New Haven, Connecticut
|| Department of Pediatrics, Emory University, Atlanta, Georgia
Department of Pediatrics, University of Alabama, Birmingham, Alabama
# Department of Pediatrics, Brown University, Providence, Rhode Island
** Department of Pediatrics, University of Miami, Miami, Florida
{ddagger}{ddagger} Department of Pediatrics, Wake Forest University, Winston-Salem, North Carolina
§§ Department of Pediatrics, University of Texas, Southwestern, Dallas, Texas
|||| Department of Pediatrics, Wayne State University, Detroit, Michigan
¶¶ Department of Pediatrics, Duke University, Durham, North Carolina
## Department of Pediatrics, University of Rochester, Rochester, New York
*** Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio
{ddagger}{ddagger}{ddagger} Department of Pediatrics, Sharp Mary Birch Hospital, San Diego, California
§§§ Department of Pediatrics, Indiana University, Indianapolis, Indiana
|||||| Department of Pediatrics, Stanford University, Palo Alto, California
¶¶¶ Department of Pediatrics, University of Texas, Houston, Texas

Objective. Bronchopulmonary dysplasia (BPD) is the endpoint of many intervention trials in neonatology, yet the outcome measure when based solely on oxygen administration may be confounded by differing criteria for oxygen administration between physicians. We previously reported a technique to standardize the definition of BPD between sites by using a timed room-air challenge in selected infants. We hypothesized that a physiologic definition of BPD would reduce the variation in observed rates of BPD among different neonatal centers.

Methodology. A total of 1598 consecutive inborn premature infants (501–1249 g birth weight) who remained hospitalized at 36 weeks' postmenstrual age were prospectively assessed and assigned an outcome with both a clinical definition and physiologic definition of BPD. The clinical definition of BPD was oxygen supplementation at exactly 36 weeks' postmenstrual age. The physiologic definition of BPD was assigned at 36 ± 1 weeks' postmenstrual age and included 2 distinct subpopulations. First, neonates on positive pressure support or receiving >30% supplemental oxygen with saturations between 90% and 96% were assigned the outcome BPD and not tested further. Second, those receiving ≤30% oxygen or effective oxygen >30% with saturations >96% underwent a room-air challenge with continuous observation and oxygen-saturation monitoring. Outcomes of the room-air challenge were "no BPD" (saturations ≥90% during weaning and in room air for 30 minutes) or "BPD" (saturation <90%). At the conclusion of the room-air challenge, all infants were returned to their baseline oxygen levels. Safety (apnea, bradycardia, increased oxygen use) and outcomes of the physiologic definition versus the clinical definition were assessed.

Results. A total of 560 (35.0%) neonates were diagnosed with BPD by the clinical definition of oxygen use at 36 weeks' postmenstrual age. The physiologic definition diagnosed BPD in 398 (25.0%) neonates in the cohort. All infants were safely studied. There were marked differences in the impact of the definition on BPD rates between centers (mean reduction: 10%; range: 0–44%). Sixteen centers had a decrease in their BPD rate, and 1 center had no change in their rate.

Conclusions. The physiologic definition of BPD reduced the overall rate of BPD and reduced the variation among centers. Significant center differences in the impact of the physiologic definition were seen, and differences remained even with the use of this standardized definition. The magnitude of the change in BPD rate is comparable to the magnitude of treatment effects seen in some clinical trials in BPD. The physiologic definition of BPD facilitates the measurement of BPD as an outcome in clinical trials and the comparison between and within centers over time.


Key Words: premature infant • bronchopulmonary dysplasia • chronic lung disease • test • methodology

Abbreviations: VLBW, very low birth weight • BPD, bronchopulmonary dysplasia • lpm, liters per minute • STOP-ROP, Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity • FIO2, fraction of inspired oxygen • IRB, institutional review board


Accepted May 20, 2004.




This article has been cited by other articles:


Home page
NeoReviewsHome page
R. Ramanathan
Pharmacology Review: Bronchopulmonary Dysplasia and Diuretics
NeoReviews, June 1, 2008; 9(6): e260 - e267.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. C. Eichenwald and A. R. Stark
Management and Outcomes of Very Low Birth Weight
N. Engl. J. Med., April 17, 2008; 358(16): 1700 - 1711.
[Full Text] [PDF]


Home page
PediatricsHome page
E. S. Shinwell, B. Reichman, L. Lerner-Geva, V. Boyko, I. Blickstein, and in collaboration with the Israel Neonatal Network
"Masculinizing" Effect on Respiratory Morbidity in Girls From Unlike-Sex Preterm Twins: A Possible Transchorionic Paracrine Effect
Pediatrics, September 1, 2007; 120(3): e447 - e453.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
M. Walsh, A. Laptook, S. N. Kazzi, W. A. Engle, Q. Yao, M. Rasmussen, S. Buchter, G. Heldt, W. Rhine, R. Higgins, et al.
A Cluster-Randomized Trial of Benchmarking and Multimodal Quality Improvement to Improve Rates of Survival Free of Bronchopulmonary Dysplasia for Infants With Birth Weights of Less Than 1250 Grams
Pediatrics, May 1, 2007; 119(5): 876 - 890.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. A. Parikh, R. E. Lasky, K. A. Kennedy, F. R. Moya, L. Hochhauser, S. Romo, and J. E. Tyson
Postnatal Dexamethasone Therapy and Cerebral Tissue Volumes in Extremely Low Birth Weight Infants
Pediatrics, February 1, 2007; 119(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Fabres, W. A. Carlo, V. Phillips, G. Howard, and N. Ambalavanan
Both Extremes of Arterial Carbon Dioxide Pressure and the Magnitude of Fluctuations in Arterial Carbon Dioxide Pressure Are Associated With Severe Intraventricular Hemorrhage in Preterm Infants
Pediatrics, February 1, 2007; 119(2): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
V. Tommiska, K. Heinonen, L. Lehtonen, M. Renlund, T. Saarela, O. Tammela, M. Virtanen, and V. Fellman
No Improvement in Outcome of Nationwide Extremely Low Birth Weight Infant Populations Between 1996-1997 and 1999-2000
Pediatrics, January 1, 2007; 119(1): 29 - 36.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
E S Shinwell, L Lerner-Geva, A Lusky, B Reichman, and in collaboration with the Israel Neonatal Network
Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F30 - F33.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
D Quine, C M Wong, E M Boyle, J G Jones, and B J Stenson
Non-invasive measurement of reduced ventilation:perfusion ratio and shunt in infants with bronchopulmonary dysplasia: a physiological definition of the disease
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2006; 91(6): F409 - F414.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. R. Payne, M. LaCorte, P. Karna, S. Chen, M. Finkelstein, J. P. Goldsmith, J. H. Carpenter, and on behalf of the Breathsavers Group
Reduction of Bronchopulmonary Dysplasia After Participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative
Pediatrics, November 1, 2006; 118(Supplement_2): S73 - S77.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
A. H. Jobe
The New BPD
NeoReviews, October 1, 2006; 7(10): e531 - e545.
[Full Text] [PDF]


Home page
NEJMHome page
D. M. Coulter, I. L. Hand, L. M. Noble, B. Schmidt, R. S. Roberts, P. Davis, and the Caffeine for Apnea of Prematurity Trial Invest
Caffeine for apnea of prematurity.
N. Engl. J. Med., August 31, 2006; 355(9): 958 - 959.
[Full Text] [PDF]


Home page
NEJMHome page
R. A. Ballard, W. E. Truog, A. Cnaan, R. J. Martin, P. L. Ballard, J. D. Merrill, M. C. Walsh, D. J. Durand, D. E. Mayock, E. C. Eichenwald, et al.
Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
N. Engl. J. Med., July 27, 2006; 355(4): 343 - 353.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. Schmidt, R. S. Roberts, P. Davis, L. W. Doyle, K. J. Barrington, A. Ohlsson, A. Solimano, W. Tin, and the Caffeine for Apnea of Prematurity Trial Group
Caffeine Therapy for Apnea of Prematurity
N. Engl. J. Med., May 18, 2006; 354(20): 2112 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. Altiok, R. Yasumatsu, G. Bingol-Karakoc, R. J. Riese, M. T. Stahlman, W. Dwyer, R. A. Pierce, D. Bromme, E. Weber, and S. Cataltepe
Imbalance between Cysteine Proteases and Inhibitors in a Baboon Model of Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 318 - 326.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. A. Ehrenkranz, M. C. Walsh, B. R. Vohr, A. H. Jobe, L. L. Wright, A. A. Fanaroff, L. A. Wrage, K. Poole, and for the National Institutes of Child Health and Hu
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
Pediatrics, December 1, 2005; 116(6): 1353 - 1360.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. N. Finer
Nasal Cannula Use in the Preterm Infant: Oxygen or Pressure?
Pediatrics, November 1, 2005; 116(5): 1216 - 1217.
[Full Text] [PDF]


Home page
PediatricsHome page
M. Walsh, W. Engle, A. Laptook, S. N. J. Kazzi, S. Buchter, M. Rasmussen, Q. Yao, and for the National Institute of Child Health and Hum
Oxygen Delivery Through Nasal Cannulae to Preterm Infants: Can Practice Be Improved?
Pediatrics, October 1, 2005; 116(4): 857 - 861.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. P. Van Meurs, L. L. Wright, R. A. Ehrenkranz, J. A. Lemons, M. B. Ball, W. K. Poole, R. Perritt, R. D. Higgins, W. Oh, M. L. Hudak, et al.
Inhaled Nitric Oxide for Premature Infants with Severe Respiratory Failure
N. Engl. J. Med., July 7, 2005; 353(1): 13 - 22.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. C. Beckerman
Physiologically Redefining Bronchopulmonary Dysplasia
Pediatrics, March 1, 2005; 115(3): 830a - 831.
[Full Text] [PDF]